Stock Watch: Drug Safety In The Spotlight
Three FDA Clinical Holds In The Shortened Thanksgiving Week May Have Wider Implications
Are three FDA clinical holds in less than four days a symptom of lax safety programs at some biotech companies? And what does the latest publication on Aduhelm say about the relationship between safety and accelerated approval?
